bf/NASDAQ:CORT_icon.jpeg

COM:CORCEPT

Corcept Therapeutics

  • Stock

Last Close

46.89

31/10 20:00

Market Cap

3.19B

Beta: -

Volume Today

2.67M

Avg: -

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Biotechnology
  • website

    corcept.com/
  • ipo date

    Apr 14, 2004

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrom...Show More

peer of

competitor of